Skip to main content

Predictive and Prognostic Factors for the Outcome of the Patients Receiving Pegylated Liposomal Doxorubicin for Advanced Breast Cancer

Research Abstract
NULL
Research Authors
Salah Mabrouk,Jasmine Roshdy,Abeer Ibrahim
Research Department
Research Journal
Advances in Breast Cancer Research
Research Pages
13
Research Publisher
scientific research publishing
Research Rank
1
Research Vol
09(02)
Research Website
NULL
Research Year
2020

DFT and Thermal Decomposition Studies
on Gemcitabine

Research Abstract
NULL
Research Authors
Ereen Rezkallah, Abeer Ibrahim, AbdelRahman Dahy,
Ahmed Abdel Hakiem and Refaat Mahfouz
Research Department
Research Journal
Zeitschrift für Physikalische Chemie
Research Member
Research Pages
25
Research Publisher
DE Guryter
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2019

DFT and Thermal Decomposition Studies
on Gemcitabine

Research Abstract
NULL
Research Authors
Ereen Rezkallah, Abeer Ibrahim, AbdelRahman Dahy,
Ahmed Abdel Hakiem and Refaat Mahfouz
Research Journal
Zeitschrift für Physikalische Chemie
Research Pages
25
Research Publisher
DE Guryter
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2019

DFT and Thermal Decomposition Studies
on Gemcitabine

Research Abstract
NULL
Research Authors
Ereen Rezkallah, Abeer Ibrahim, AbdelRahman Dahy,
Ahmed Abdel Hakiem and Refaat Mahfouz
Research Journal
Zeitschrift für Physikalische Chemie
Research Pages
25
Research Publisher
DE Guryter
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2019

Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center

Research Abstract
NULL
Research Authors
Salah Mabrouk,Jasmine Roshdy,Abeer Ibrahim
Research Department
Research Journal
Journal of the Egyptian National Cancer Institute
Research Member
Research Pages
10
Research Publisher
Springer
Research Rank
1
Research Vol
32(20)
Research Website
NULL
Research Year
2020

Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center

Research Abstract
NULL
Research Authors
Salah Mabrouk,Jasmine Roshdy,Abeer Ibrahim
Research Department
Research Journal
Journal of the Egyptian National Cancer Institute
Research Member
Research Pages
10
Research Publisher
Springer
Research Rank
1
Research Vol
32(20)
Research Website
NULL
Research Year
2020

Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center

Research Abstract
NULL
Research Authors
Salah Mabrouk,Jasmine Roshdy,Abeer Ibrahim
Research Department
Research Journal
Journal of the Egyptian National Cancer Institute
Research Pages
10
Research Publisher
Springer
Research Rank
1
Research Vol
32(20)
Research Website
NULL
Research Year
2020

Outcomes of Early-stage Glottic Carcinoma Treated with Radiation Therapy: A Single Institution Experience

Research Abstract
Objective: To evaluate the outcomes of radical intent radiation therapy in early glottic carcinoma (EGC), including local control rate (LCR), disease-free survival (DFS), death specific free survival (DSFS), and overall survival (OS) rates, in Saudi patients treated at a single institution. Materials and methods: This is an institutional review board (IRB) approved, retrospective study of 27 patients with T1-2 N0 M0, early glottic carcinoma (EGC) who were treated from 2010 to 2015 at our institution with different radiotherapy (RT) fractionation regimens. The regimens included six different fractionation schedules of radiotherapy (RT): 50 Gy (20 x 2.5 Gy) dose prescribed to 95% isodose line, 52.4 Gy (20 x 2.52 Gy), 63 Gy (28 x 2.25 Gy), 66 Gy (33 x 2 Gy), and 70 Gy (35 x 2 Gy). The cohort was stratified into two groups, ≤ 52.5 Gy (n=15) and > 52.5 Gy (n=12). The median follow-up of all patients was 31.7 months (range 7-82). Results: The mean age of the cohort was 64.5 years (median 65, range: 41-83). Eleven patients (40.7%) had a history of smoking. The majority of the cohort was with T1a EGC (70.4%, n=19), and anterior commissure invasion was seen in three patients (11.1%). The mean RT doses were 55.6 Gy (range: 50-70). The five-year LCR, DFS, DSFS, and OS rates were 83.1%, 80.0%, 96.2%, and 92.6%, respectively. The LCR rates for those receiving a dose of 52.5 Gy or less were 61.3 months compared to 89.5 months for those who received more than 52.5 Gy (p=0.994). Nonsmokers and patients with an unknown smoking history achieved a five-year LCR of 100%, while patients with a positive smoking history achieved a five-year LCR of 60.6% (p=0.044). Conclusion: Radiation therapy for EGC in our patients showed reasonable five-year LCR with larynx preservation at 83.1%, DFS 80.0%, five-year OS rate 92.6%, and DSFS rate 96.2%. We found that smoking had a significant correlation with LCR. However, large prospective trials are warranted to evaluate the efficacy of overall treatment time, dose per fraction of above 2 Gy, and smoking effect.
Research Authors
Mubarak AlQahtani, Ahmed M. Maklad, Muhammad Shuja, Khalid H. AlQahtani, Hussain AlHussain, Saleh F. AlDhahri, Abdullah AlAmro, Moamen M. Aly, Mutahir A. Tunio, Amal Marie, Feras Alkholaiwi, Nasser Alobida, Ayman A. Elghazaly, Yasser Bayoumi
Research Journal
Cureus
Research Pages
NULL
Research Publisher
Cureus
Research Rank
1
Research Vol
10(10): e3444
Research Website
DOI 10.7759/cureus.3444
Research Year
2018

A Retrospective comparison of two immobilization systems for soft-tissue sarcomas of extremities

Research Abstract
Purpose or Objective: Our aim was to compare Vac-Lok™ and thermoplastic casts differences in interfraction set-up reproducibility in patients treated with three-dimensional conformal radiotherapy (3DCRT) for soft tissue sarcomas (STS) of extremities. Material and Methods: Retrospective review of patients with STS of extremities treated with 3DCRT was performed. Immobilization was performed for 14 patients (Vac-LOKTM= 7; thermoplastic cast = 7). A total of 307 measurements of set-up errors in each direction (vertical, longitudinal, lateral and rotational) were collected. Random (σ) and systemic errors (Σ) were computed. To evaluate the overall shift from isocenter, total vector error (TVE) was also calculated. To assess absolute mean differences between the immobilization systems, independent samples t-test was performed. Results: Median age of patients was 43.8 years (range: 18-74). Predominant STS site was lower extremity (57.1%). Preoperative RT was given to 5 patients (35.7%) and postoperative RT was given to 9 patients (64.3%). Mean displacements for the Vac-Lok™ and thermoplastic cast, respectively, were as follows: vertical, -0.01±0.06 cm vs. 0.02±0.16 cm (P = 0.63); longitudinal, 0.03±0.04 cm vs. 0.04±0.07cm (P = 0.60); lateral, 0.04±0.17cm vs. 0.00±0.11cm (P = 0.55) and TVE, 0.15±0.10 vs. 0.19±0.07 (P = 0.44). No statistical differences were seen in σ or Σ between Vac-Lok™ and thermoplastic cast. Similarly, no statistical differences were seen in the margins calculated for each axis using the two immobilization systems by using van Herk’s formula. Conclusion: Based on the findings of our study, we concluded that both the Vac-Lok™ immobilizer and thermoplastic cast had comparable results, as both systems offered better reproducibility during RT in STS of extremities without significant daily set-up displacement. A prospective study needs to be undertaken on a larger scale to better explore the outcomes of patient immobilization systems.
Research Authors
M.M.O.M. Aly, V.M. Gurusamy, A.M. Maklad, M. Tunio, M. Shuja, R. Mohammed, A.A. AlHazineh, Y. Bayoum
Research Journal
Radiotherapy and Oncology
Research Pages
S1224-S1225
Research Publisher
Radiotherapy and Oncology
Research Rank
3
Research Vol
127
Research Website
NULL
Research Year
2018

Efficacy of 8 Gy Single Fraction Palliative Radiation Therapy in Painful Bone Metastases: A Single Institution Experience

Research Abstract
Introduction: Bone metastasis (BM) is a major complication of many solid tumors like breast, prostate, lung and renal cancers. BM leads to serious sequelae of pain, fractures, spinal cord compression and hypercalcemia. Radiotherapy has an established role in relieving pain caused by BM. Worldwide different radiotherapy schedules are being used for BM. The aim of this study is to determine the efficacy of single fraction palliative radiotherapy for painful bone metastases. Methods: Between April 2014 and April 2017, single fraction radiotherapy was used to treat 73 patients in our institution. They had pathologically proven breast, prostate, lung or renal cancer with radiological evidence of bone metastases. There were 39 males (53%) and 34 females (47%). The median age was 58 years (range 33–87 years). 39% patients (n = 28) had breast cancer, 35% had prostate cancer (n = 26), 23% had lung cancer (n = 17), and 3% had renal cancer (n = 2). On presentation, all the patients had a pain score of more than five on Brief Pain Inventory (BPI). Results: Response assessment to pain after three months from single fraction radiotherapy was found to be complete response (CR) in 23% patients (n = 17), partial response (PR) in 38% patients (n = 28), stable disease (SD) in 26% patients (n = 19) and progressive disease (PD) in 12% patients (n = 9). The overall efficacy of treatment was 62%, with CR 23% and PR 38%. Pre-treatment mean pain score was 8.15 compared to 4.68 post-treatment (p 0.001). Conclusions: Single fraction palliative radiotherapy of 8 Gy showed significant efficacy in painful bone metastases in our setting and merits further investigation in our population.
Research Authors
Muhammad Shuja, Ayman A. Elghazaly, Asif Iqbal, Reham Mohamed, Amal Marie, Mutahir A. Tunio, Moamen M. Aly, Ali Balbaid, Mushabbab Asiri
Research Journal
Cureus
Research Pages
NULL
Research Publisher
Cureus
Research Rank
1
Research Vol
10(1): e2036.
Research Website
DOI 10.7759/cureus.2036
Research Year
2018
Subscribe to